O'Keeffe Charles B 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 12, 2023
Insider Transaction Report
Form 4
O'Keeffe Charles B
Director
Transactions
- Award
Options to purchase common stock
2023-12-08+29,524→ 290,024 totalExercise: $14.15Exp: 2030-12-08→ Common Stock (29,524 underlying) - Award
Restricted stock units
2023-12-08+4,240→ 294,264 total→ Common Stock (4,240 underlying)
Footnotes (3)
- [F1]Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F3]Shares of common stock will be delivered to the Reporting Person upon vesting.